Peer-reviewed discovery platform and data in PNAS show that single transcription factor modulation reverses aging-associated gene expression and restores healthy cellular and tissue function in models ...
A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...
New angles on growth shape self-help books for 2026, where clarity, resilience and intention matter more than trends or ...
News-Medical.Net on MSN
Reprogramming immunity to protect beta cells in type 1 diabetes
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...
Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have ...
KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...
Interior says it is only restructuring internally, though it is still working toward Trump's goal of an interagency merger.
Old age has been venerated and celebrated—and dreaded—by human cultures since ancient times.
STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration with Alida ...
For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important ...
The Daily Digest on MSN
The new longevity paradox: Living longer while fearing time itself
Longevity has become one of the most paradoxical achievements of the 21st century. For the first time in human history, vast ...
GC Therapeutics, Inc. (GCTx), a biotechnology company created to scale and unlock the next generation of cell therapy-based medicines through its TFome™ cellular programming platform, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results